A company that aims to treat neurological conditions such as ADHD and autism has made a dizzying share price surge without a single sale. It has made its founder very rich.
A company that aims to treat neurological conditions such as ADHD and autism has made a dizzying share price surge without a single sale. It has made its founder very rich. Business / Companies Sydney Morning Herald – Latest News